High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design.
Acta Crystallogr D Struct Biol
; 74(Pt 10): 1015-1026, 2018 Oct 01.
Article
em En
| MEDLINE
| ID: mdl-30289412
Here, new crystal structures are presented of the isolated membrane-proximal D1 and distal D2 domains of protein tyrosine phosphatase epsilon (PTPâ), a protein tyrosine phosphatase that has been shown to play a positive role in the survival of human breast cancer cells. A triple mutant of the PTPâ D2 domain (A455N/V457Y/E597D) was also constructed to reconstitute the residues of the PTPâ D1 catalytic domain that are important for phosphatase activity, resulting in only a slight increase in the phosphatase activity compared with the native D2 protein. The structures reported here are of sufficient resolution for structure-based drug design, and a microarray-based assay for high-throughput screening to identify small-molecule inhibitors of the PTPâ D1 domain is also described.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Desenho de Fármacos
/
Análise Serial de Proteínas
/
Proteínas Tirosina Fosfatases Classe 4 Semelhantes a Receptores
/
Domínios Proteicos
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article